Skip to main content
. 2005 Apr 7;11(13):1976–1980. doi: 10.3748/wjg.v11.i13.1976

Table 4.

Main outcome measurements for patients with CHB treated with interferon-α 2a.

Response outcome Total HBeAg positive Anti-HBe positive P
Viral response n % % %
3rd mo 47 53.4 36.3 63.6 <0.01
6th mo 38 43.1 27.2 52.7 <0.05
12th mo 26 29.5 18.1 36.3 >0.1
Biochemical response
3rd mo 30 34.1 21.2 41.8 >0.5
6th mo 26 29.5 24.2 32.7 >0.5
12th mo 25 28.4 24.2 30.9 >0.5
Serological response
3rd mo 4 12.1 12.1
6th mo 7 21.2 21.2
12th mo 8 24.2 24.2